Exact Sciences Cor (EXAS)

Jan 13, 2025, 1:04 PM EST - 4 days ago

Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market

Jan 12, 2025, 7:00 PM EST - 5 days ago

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Jan 2, 2025, 6:00 AM EST - 15 days ago

Exact Sciences to Participate in J.P. Morgan Healthcare Conference

Dec 9, 2024, 10:01 AM EST - 5 weeks ago

AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates

Dec 4, 2024, 11:06 AM EST - 6 weeks ago

Exact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)

Dec 3, 2024, 12:02 PM EST - 6 weeks ago

Exact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)

Dec 2, 2024, 9:30 AM EST - 6 weeks ago

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Nov 26, 2024, 1:24 PM EST - 7 weeks ago

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)

Nov 26, 2024, 12:21 PM EST - 7 weeks ago

Why Is Exact Sciences Stock Trading Higher On Monday?

Nov 26, 2024, 6:00 AM EST - 7 weeks ago

Exact Sciences to Participate in December Investor Conferences

Nov 25, 2024, 5:35 PM EST - 7 weeks ago

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024

Nov 19, 2024, 4:07 PM EST - 2 months ago

Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript)

Nov 18, 2024, 8:00 AM EST - 2 months ago

Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community

Nov 13, 2024, 1:00 PM EST - 2 months ago

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy

Nov 10, 2024, 11:39 AM EST - 2 months ago

Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap.

Nov 6, 2024, 12:36 PM EST - 2 months ago

Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount

Nov 6, 2024, 10:13 AM EST - 2 months ago

Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point

Nov 6, 2024, 7:58 AM EST - 2 months ago

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HMC SMCI

Nov 5, 2024, 9:06 PM EST - 2 months ago

Exact Sciences Corporation (EXAS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 4:05 PM EST - 2 months ago

Exact Sciences Announces Third-Quarter 2024 Results

Nov 1, 2024, 6:00 AM EDT - 2 months ago

Exact Sciences to Participate in November Investor Conference

Oct 27, 2024, 12:00 PM EDT - 2 months ago

Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement

Oct 8, 2024, 6:00 AM EDT - 3 months ago

Exact Sciences Schedules Third Quarter 2024 Earnings Call

Oct 7, 2024, 2:05 PM EDT - 3 months ago

FMR LLC Bolsters Stake in Exact Sciences Corp

Oct 6, 2024, 2:00 PM EDT - 3 months ago

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

AMGN BIIB BLUE BMY CRSP EDIT NTLA

Oct 4, 2024, 6:00 AM EDT - 3 months ago

FDA Approves Exact Sciences' Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening

Sep 16, 2024, 2:35 AM EDT - 4 months ago

Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024

Sep 12, 2024, 8:21 AM EDT - 4 months ago

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday

Sep 4, 2024, 9:43 PM EDT - 4 months ago

Exact Sciences Corporation (EXAS) at Wells Fargo 2024 Healthcare Conference - Transcript

Aug 28, 2024, 6:00 AM EDT - 5 months ago

Exact Sciences to Participate in September Investor Conferences

Aug 20, 2024, 7:00 AM EDT - 5 months ago

Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study

Aug 18, 2024, 6:51 PM EDT - 5 months ago

Exact Sciences: Cost Optimization And Product Strength

Aug 15, 2024, 7:00 AM EDT - 5 months ago

New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion

Aug 1, 2024, 2:14 PM EDT - 6 months ago

Exact Sciences Analysts Slash Their Forecasts After Q2 Results

Jul 31, 2024, 8:17 PM EDT - 6 months ago

Exact Sciences Corporation (EXAS) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 6 months ago

Exact Sciences Announces Second-Quarter 2024 Results

Jul 29, 2024, 8:05 AM EDT - 6 months ago

U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy's Petition Challenging Validity of ‘781 Patent Owned by Exact Sciences

Jul 17, 2024, 8:00 AM EDT - 6 months ago

Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening

Jul 8, 2024, 6:00 AM EDT - 6 months ago

Exact Sciences schedules second quarter 2024 earnings call

Jul 1, 2024, 8:15 AM EDT - 7 months ago

Geneoscopy Files Counterclaims Against Exact Sciences

Jun 5, 2024, 7:46 AM EDT - 8 months ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX)

INBX A TDOC

May 28, 2024, 6:00 AM EDT - 8 months ago

Exact Sciences to Participate in June Investor Conferences

May 24, 2024, 6:05 AM EDT - 8 months ago

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®

May 22, 2024, 4:05 PM EDT - 8 months ago

Court Dismisses Exact Sciences' ‘781 Patent Infringement Claim Against Geneoscopy

May 22, 2024, 7:30 AM EDT - 8 months ago

Exact Sciences Earns 2024 Great Place To Work® Certification™

May 21, 2024, 6:05 AM EDT - 8 months ago

Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy

May 10, 2024, 3:00 AM EDT - 9 months ago

The National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX® Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer Patients

May 8, 2024, 4:05 PM EDT - 9 months ago

Exact Sciences Announces First-Quarter 2024 Results

May 7, 2024, 8:00 AM EDT - 9 months ago

Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024

May 1, 2024, 6:00 AM EDT - 9 months ago

Exact Sciences to Participate in May Investor Conference